• 啟弘生技竹北新廠正式啟用，台灣邁向國際病毒載體代工

  2024-10-23 啟弘生技竹北新廠正式啟用，台灣邁向國際病毒載體代工 台灣首家GMP等級病毒載體量產廠—啟弘生技（TFBS Bioscience Inc.）竹北新廠，正式開幕，標誌著台灣細胞與基因治療產業邁向商業化階段的重大里程碑，也彰顯了台灣生技產業CDMO逐漸在全球的供應鏈中佔據關鍵地位 Learn more

• Minaris Regenerative Medicine and TFBS Announce Strategic Partnership to Advance Cell and Gene Therapy

  2024-10-02 Minaris Regenerative Medicine and TFBS Announce Strategic Partnership to Advance Cell and Gene Therapy Minaris Regenerative Medicine, LLC (Minaris) and TFBS Bioscience Inc. (TFBS) are pleased to announce a strategic partnership in cell and gene therapy (CGT) mainly in North America. This collaboration is designed to enhance their capabilities to drive industry innovation by providing the one-stop-shop solutions. Learn more

• President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA

  2024-05-08 President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA Learn more

• Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc.

  2024-04-25 Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. Learn more

• TFBS Brochure

  2023-04-07 TFBS Brochure Learn more